Ironwood Pharma (IRWD) Tops Q4 EPS by 7c

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.10), $0.07 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $45.55 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals